Uncategorized

Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access

Published

2 weeks ago

on

Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to the ALS community.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version